Ultragenyx Pharmaceutical Inc. Balance Sheet

Balance Sheet Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 161.12M100.49M113.43M433.58M713.53M307.58M132.94M213.58M173.73M
Short-term Investments 219.03M134.00M346.27M321.65M488.01M432.61M614.82M363.62M436.30M
Cash & Current Investments 380.15M234.49M459.71M755.23M1,201.53M740.20M747.76M577.21M610.02M
Receivables - Net 8.60M5.17M12.74M32.84M23.09M28.43M40.45M73.39M121.80M
Receivables - Other 10.30M2.98M17.80M9.60M16.00M6.40M1.10M1.80M
Receivables 8.60M15.47M15.72M50.64M32.69M44.43M46.84M74.49M123.60M
Work In Process 0.74M5.38M8.19M7.18M10.50M17.49M18.86M21.97M
Finished Goods 0.02M1.68M3.35M5.86M5.73M9.28M15.11M23.04M
Inventory 0.76M7.07M11.55M13.05M16.23M26.77M33.97M45.01M
Prepaid Assets 20.14M29.16M42.86M51.40M57.63M71.75M68.93M47.62M40.29M
Current Assets 401.69M269.58M522.37M851.02M1,295.30M856.60M883.90M732.18M817.12M
Non-Current Assets
Property, Plant & Equipment (Net) 17.05M21.84M20.05M44.35M73.52M141.25M259.73M290.57M265.93M
Long-Term Investments 117.96M9.97M5.17M10.51M258.93M148.97M199.90M135.00M
Goodwill 44.41M44.41M44.41M44.41M44.41M44.41M44.41M44.41M
Intangibles 141.54M129.22M129.00M131.11M131.28M163.78M173.78M178.31M
Goodwill & Intangibles 185.95M173.63M173.41M175.52M175.68M208.18M218.18M222.72M
Other Non-Current Assets 2.08M3.41M3.51M3.47M8.81M20.56M48.34M57.69M62.68M
Non-Current Assets 138.93M221.17M197.19M284.48M464.25M665.79M661.54M758.83M686.33M
Assets 540.63M490.75M719.56M1,135.50M1,759.56M1,522.40M1,545.44M1,491.01M1,503.46M
Liabilities
Current Liabilities
Accounts Payables 5.36M8.89M12.28M12.87M12.92M17.14M43.27M42.11M38.76M
Payables 5.36M8.89M12.28M12.87M12.92M17.14M43.27M42.11M38.76M
Accumulated Expenses 54.55M62.13M62.45M83.19M108.49M145.56M204.68M196.49M240.97M
Other Accumulated Expenses 5.08M8.79M9.10M18.98M24.44M42.08M52.18M31.20M19.03M
Current Leases 7.24M8.98M11.07M11.78M12.60M10.30M
Current Deferred Revenue 0.34M5.99M
Total Current Liabilities 60.26M71.01M74.72M103.30M189.61M181.37M261.21M280.44M344.15M
Non-Current Liabilities
Minority Interest 7.00M
Non-Current Deferred Tax Liability 31.17M31.17M33.31M33.31M33.31M31.67M30.06M30.06M
Operating Leases 29.76M39.25M30.90M19.81M30.57M30.04M
Other Non-Current Liabilities 6.39M5.12M4.76M315.37M335.67M351.79M875.44M862.33M819.82M
Total Non-Current Liabilities 60.26M102.18M105.89M166.36M269.51M248.05M317.51M353.27M421.33M
Total Liabilities 66.65M107.30M110.65M481.73M605.18M599.84M1,192.95M1,215.60M1,241.16M
Shareholder's Equity
Common Equity 473.97M383.45M608.91M653.76M1,154.38M922.56M352.49M275.41M255.30M
Shareholder's Equity 473.97M383.45M608.91M653.76M1,154.38M922.56M352.49M275.41M255.30M
Liabilities and Shareholders Equity 540.63M490.75M719.56M1,135.50M1,759.56M1,522.40M1,545.44M1,491.01M1,503.46M
Treasury Shares 0.57M0.82M0.95M1.30M1.68M1.67M0.01M0.07M
Retained Earnings -530.53M-832.67M-1030.28M-1433.01M-1619.58M-2073.60M-2781.02M-3387.66M-3956.84M